• 沒有找到結果。

單次電針灸治療及表面電針灸治療對頸痛病患之療效比較

N/A
N/A
Protected

Academic year: 2021

Share "單次電針灸治療及表面電針灸治療對頸痛病患之療效比較"

Copied!
7
0
0

加載中.... (立即查看全文)

全文

(1). Dêkn¼šD ¬êkn¼š.m½ š\gµ. * *[. . Q±à² ÓkýTGÁpljJ ¼ò­É/3Žà/pù–½/AY. . ÎAëÞ#Ehêkn¼šD¬êkn¼š.m½š\gµ

(2) _6  œÎo Œìá.ðá Q  à

(3) ªœ=ϼškná Q  à

(4) .ðá9"=ϳ©œhê kn¼šêšá Q  à

(5) .ðá9"=ϳ©œh¬êkn¼š}Âm½ôÂm ¬•ÂmEçFÃD~”¹fmj#½ôޤΚ\•`ïkná4h¼š¢Âm½ôòÈ N  6Âm¬_ N  6êšá4h¼š¢Âm½ôòÈ N 

(6)  6 Âm¬_ N  6¼šØ ¢knáÂm½ô N 

(7)  6êš á N 

(8) 6knáêšá4¼š¢òÈD¼šØ ¢ NKQ`¾.³ìá Âm¬_4¼š¢0g¼šHc`¾ N­ìá! NK­Q.³~”¹fmj#½ô4kn áDêšá¼šìG¢6¾ N  6 D   6 ¼šØ ¢ N  6  D 

(9) 6 Ìá! NKQ`.³äA• âhêknU¬êkn¼š.m Âm0žc\< úž4L/mƒTS‘Qj#/Ìðš\9"ƒ¬êknµQ˜¯áw }.¯™Éž:3á»Ç‰Á+     

(10)  oßm êkn  ¬êkn  

(11).     

(12).      

(13). š5Xš±kn¼šDŽ?ˆñ¹áϨ¼ šK’ÁCéàCêÕl X¯ S³ mÏñ{*‰‡€Ú½Øν–¤ > T ù°¯ ó  

(14) ¾Pìƒc§ ãབ¤|¿ D»œ¼š ˆϨ¼šUázm¼šc‰@•  OXOD0cž¯àÂm­Ø .  ­YÍA–ïΚ\*cJ ËÉ i {o<No<9{ÏuñDXÂm.5 ³Wc ½»µPGÚÁšBknˆ½¼ ¼0ŒÇ‰J¶ç½¼½6w{*‰‡€Ú« šÎ{*‰‡€Ú¯ß RƒknΗc• Îç]o<Æð«  ¼šm MKHk]kU KßàyK¶kˆ' Hn‹Cñ½únCb/ÂmY¯àÞ ÌÀt¾ 5Îtà¤|­LàAAFkc Ë$Œ/iQ± ¯ ¤/mƒ¶ç½ û§5ˏ¹ kn¼š4˜ÁÁšUáï Wcì6Øξлº1Îa}ïU»Çt æ֝¨Ø5Rc±A–ïkn¼šFmc ëH.m2Gš±’Á=ϼšϨ¼ ‰@š\ ­KœƒΉ͚\%Ï ¢ 8G_ P  a  _ Ò<_ P  a  _ $æ_ P  a  _ iÎöä3ìB Á0Q%±à² ÓkýTGÁpljJ”¾  ’¡[~®  s ê– ¼ /Ì. 0 .  

(15)  

(16).    

(17)     . . . >@. >@.      

(18)  .  . 

(19)  . . >@. . >@. . . . >@. . . >@. >@.  .  .    .   .  .

(20) . »ÇYÁ+   

(21)    . E³ŝ.Ϩ¼šUkn¼šA0}¼šØ Κ€ *O D

(22) U Îaˆ ½#EÎ š\ESÿ{D¼šš\AëH¼0 mÁp15Ϩ¼š0n‹5€ΈžazKô _KÌ ì ?AzEÎA}ljJç m½.ê –

(23) _½Üš¢ ‹m½49"=ϼšíh*hêkn ¼šUh¬êkn ¼š.Îljš\ÏÎcY.³ –AvK)hêknU¬êkn¼š.Î mÂmcY< Kߞ4àç¤Ú'ží/Ã4 çÈ.½ÉhòÈQ¼š}< Î¾Ð . 

(24) . . . >@. .   

(25).  .   

(26). ,^^±.    

(27). . >@.

(28). . .

(29). . . >@. .     

(30) .  

(31) 

(32)  

(33)  

(34) . >@. . >@. .  . .  

(35).  

(36)    . >@. ÎA4 P aŒ  P  a\0/m ŒÙ¡¾ÁpljJç¶çç½A. êm M4JÇÂmËwx!ÐmŒ ¢JUŒ÷JÀco<ÿœ˜æ¨vcí ¶K}5uÅØ 0c$漚ð CÅå¸Z3ÖQ¼½•I(ðD Q±‡áÆ=ð B¹Ua‡

(37) ˆ\0¤^’ÁQ ¾Pì ¯iìÂmDa!ˆOœ½ 0$æŽß¨/mäD ; mä§Qm  MÂma!zØ ²§QKØ ŒìÎ aYQKzìÎa}ï½

(38) _½Fð ᪜þ‡= > Æ=   

(39)  

(40) ‰‡ëR  

(41)  DØUOGÌìhÌìGkn á.ðá9"=ϳ©œhêkn¼ šêšá.ðá9"=ϳ©œh ¬êkn¼šêknD ¬êkn0ä"؜Žà L.Kkn*~ljÞJÁ0ǖ êkn}kçâñUáz¼šmñœՎ ÷! D²p ±ñ œknkÖ &ξ’ ­ózôbQk çâñœœ8kž½æ ˆ JU«k Ç Èßkätê!>$Ìgêbïí½  ùý$<  ÷!$½²p½÷!$ ²p tê! û˜ Œ½cÇ­ŒÂmDËû˜u |žŒ ¤  ù Õla!  6׬êknêÂo<}Y@ZK &X  êÂoNI4kn á9"ñœï­Bkná€tê!œ 6 ×êÕl . Âm}Âm½ô  m¬•  D-çFà – Þ¤Âm½ô<}QҘé36>ïÌÑ6¾ƒ mDum°½ëHÂmæ @ämь½>ïüÓ}3ü ïÂm¬_KÏ}_c£þïÒE¬à m&°½ÂmœI}B"KK½¬_ Ö^QßÎY«¬_z6gñÖX6ô Âm -çFÃK}Âm-ç@umG-çFí }3] ï}ïì5Þ¤6¾4¼šHDØ ¢ @knáDêšáK4¼š¢òÈݳœØ h@ ‘QjK}~”¹fmj½ô     

(42)   

(43)  Þ¤Î@šc  ß# O#6ôä  6Á6  Œ  66ô^|ƒ ‘Qj^Î#Þ¤6¾4¼šH¼šì G¢DØ ¢ìÎañ@ š\Þ¤K}ï—'#½ô< ½þÎ M¼š¢¼šH6ô.³会¢’Á¼ š¢òÈìG¢DØ ¢6ô4¼šH6 ôÂmEçFÃ< ^ƒÎÂmš\^ @Âm½ôÂm¬_D~”¹fmj½ôÎ <”‘ÃÎ N”:ï—'5Þ¤0 äâ½6áÉ@ðǖ •}ÀîÃþä.ïÄΤ^} FKLVTXDUH U 6WXGHQW W m 'á!¼šHÀîÃD¼š¢< .³} 6WXGHQW W m "á!μšH¢<K} SDLUHG W m S Ãz  aÛc`¾.³. . . _ . ÎA\0  œ½ wQ  œQ  œ

(44)  Pì6¶ä  Ќ  ЧQm« ²§Q « ;Q« .ðá  œkná  œ êšá  œ'á!ÎQ¾Pì ¯iìÎ DÂma!0Q.³  ìáÂm½ôÂm¬ _ÂmEçFÃD~”¹fmj#½ô4¼šHú Q`¾.³   Âm½ô^¬knáDêšá4$æh¼š ¢6¾òÈ N   6 

(45)   D   6 

(46)   ­Ìá! NKQ`¾.³Ø ¢ =Ïá N   6 

(47)   kná N   6 

(48)   êšá N   6

(49)   knáD êšág¼šHc`¾ N­ìá! NKQ `¾.³.

(50) DêknD ¬êknš\.  ½ÄΤ^ 5ë Q¾ w  ÀîPì Ð ¯ {çm '{çm iì c Q Âma! §Q ²§Q ;Q. Q 

(51). =Ïá. kná. êšá. Q 

(52). Q 

(53). Q 

(54). S. Ã.  . . . . . .

(55).    .   .   . . . . . . . . . . . . . . . . . . . . . . . . . Âm6ôD¼šH¢< . 5ë. Âm½ô .ðá kná êšá à 'á!gµ Âm¬_ .ðá kná êšá à 'á!gµ ÂmEçFà .ðá kná êšá à 'á!gµ  S. S. S. S  . ¼šH Àîà þä. . . . .  . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . .  S . . . . . S . . . . . . . . .

(56). .  . . .

(57). ¼šØ ¢ Àîà þä. . . . . S  . ¼š¢òÈ Àîà þä.. . .

(58). ¼š¢. m@"á!<ì.³.  . .

(59) . »ÇYÁ+   

(60)    .  ‘QjD¼šH¢< 5ë. ¼šH ÀîÃHþä.. ¼šìG¢ ÀîÃHþä.. ~”¹fmj½ô    .ðá       kná       êšá    S à 'á!gµ

(61)   S   S  m@"á!<ì.³ Âm¬_^¬knáDêšá4h¼š¢ `còÈQ< 6¾ N  6 D 

(62) 6  ­Ìá! NKQ`¾.³Ø ¢ .ðá N  6  kná N   6  êšá N  6 ìá0g¼š Hc`¾< ­ìá! NKQ`.³ ÂmEçFÃ^¬h¼š­Q`òÈQ<  Ø ¢.ðá\N  3]kná N  3 ]êšá N 

(63)  3]ìá!¼šH¼š¢ D'á0 N0Ï¿cM.³ ~”¹fmj½ô^¬¼šìG¢kná N  6 êšá N  6 ¼ šØ ¢kná N 

(64) 6 êšá N  6 ÌἚ¢6ô0g¼šHc `< 9.3.ðá4¼šìG¢ N  6  Ø ¢ N  6

(65) μš¢< ­Q¿Úï–¾.³ìá!<K4¼ šìG¢Ø ¢0Q–.³ Íàúk."Âma!§Q²§Q;Q. 6¸6¾ –ڍ6˜ō9". - ¢. m¼šëÞ44E½Âm ƒ< Î àÿa³v4§Q²§QaQ±ßm ¨  ½È» â;QÎA`ïQ¢Ï§Q²§ QUYQmhêknU¬êkn¼š0ž c\òÈ< ÎÂmFΑQjúž4¼š¢ ÐìG`< ŒØ aÂm½ôD‘Qj*c ºQ3 N­Ìð!š\KQ–¾.³ êÕl¶ÎÕl¤ž6|D²ÌÌÜ. <. ¼šØ ¢ ÀîÃHþä.          . ïñáCéàCêÕl|Õl3á a+] ¤µz PVHFÕlêµ² ¯áç¨}E¯áltf[›³àCœ ƒ: ØfŽKæ!àCœ¿dm¯áÈ8Í Øç¨ E²àCêÕl Τ µ Õlêµ | ίáç¨<}êÕlýàCÖN0/Q\ ª½¿Xdm¯á ŒzknK<-Å:دá ÕlýàCÖxowÏ B D ˆ ¿Xdm¯ái ³knúžÕlýàC¯àيÙõ D }ûdm¯á /²àCêÕl kn¯áw¬HðëÍwknCéàCê Õl ÎAôá¬êknêÂo3ä ç /Ü4zÎêÂo<ÂKßœyXÏØÌY QkéÞknñœêš"zØ éFí CéàCêÕlžá$ßA3xI4ñœï ºknǖð"CšD+ÎAJ¼ š0ä"؜ŽàL.Kkn*~ljJÁ0Ç –i³:ôknǖð¶B½Þ½um G D‰oÆÂmGˆ½ôDñœÎA3äÚ ØހYcÎo0ôD9"ñœBižºà yÍ¿]ÞX hêknDh ¬êknF¯ŽwH ñ  6×­ÌÒ¹ákêknΗµÍ,ÚQ ÎA5Q£Àt¾¯à­knǞ*Àc ¶k•KþÖ$Œˆ ˆÀt¾i³ knǖn‹kn.K*~ðwμš^Qñ/ knǖðÎàCšD+ƒ"9E3¬ êknH}F¯.½ú»DXË_c     

(66)   . . >@. >@. .   

(67)  .  

(68)   . . >@.   

(69).   . >@. >@. . . .

(70) KþÖ·ËFPÁðDµPàˆh*˜.ð úžËá Õà.ð܏šÏAÞu|äKRƒkn A/knǖðÅ »â½cQYk w½ú }6ðcQÌÒÕl ÇAkǖÕà@c Îçq½c/ðAØÌIÐknk é r$ÈaÎÑ»ºz¹½ckÕÇ ž iIÐk%ÏUá4ÎA >@. >@. >@. _ ¢. m . ÎAĨ’BD­ù–½/A Yúb9"/ÝÄ. £R[¥.  

(71) 

(72)           

(73)      !"#$   

(74)  

(75)       

(76)  

(77) 

(78)  

(79)    

(80) 

(81)   

(82)  

(83)  

(84)  ! 

(85)  "

(86)  #$$%&'()(##$.   .  

(87)  .      

(88)      !

(89). * >Å3ˆ¼àæljÁš ¼½6MAÕ}”JŒJãÁp¼» ljÁ+   

(90)

(91)         

(92)     

(93)         .  

(94)       . 

(95). . ! "# 

(96) "  $ %  %&%  %  &. '. ( )

(97). * . +

(98) , -.! / 0! 1 -*

(99) *)(%   ).  

(100)  

(101)   

(102)     !

(103)  "# $  "% &

(104) ' ( ) %  

(105)  & %

(106)  * &  . 

(107)  .

(108)  . .  .  . .  . . . . ! 

(109) ". #.

(110).  . $. %. 

(111) &  ' 

(112)   

(113)    ( 

(114).  

(115)   .  Üñ½¾Þkn¼šбÍ­” 0Íä                 !    

(116)  

(117)          . ŽhêknD¬êknHFm½ Âmc9"òÈQD<dQ< úž4LΑ Qj#¬êkn/Θ¯áµLw}F¯ ™Éž:3á.  . DêknD ¬êknš\. !"

(118) #$     %. RI FKURQLF FHUYLFDO SDLQ $ SLORW VWXG\ &OLQ ([S 5KHXPDWRO .  

(119)     

(120)

(121)             

(122)  !"#$%&$'% ( ) *+ ,-) * . 

(123)  / 

(124)  .  0 

(125)           

(126) 1 -      (  '#$$& $"'''  ./ . 

(127)  . . 

(128)  2 )

(129) ) 0

(130)  

(131)     ) 1 )    0

(132) 

(133)

(134) & 0      (  ''#$$&'%! 0  3

(135)  45 . 6.    

(136)  3 0      )  .   

(137) 1 -       01 1   1   .  .

(138)

(139) -    01 / 

(140)

(141)

(142)        .   ! ". ## $. # %!% # & $'    ! %$  % %   $ % ! $$! ( %!   % ) $ $ !) *$+    %  !

(143)

(144)

(145) ,, , -. 

(146)  

(147)      . XVH ZLWK SDWLHQW SDLQ GUDZLQJV 3DLQ  0DUJROLV 5% &KLEQDOO -7 7DLW 5& 7HVWUHWHVW UHOLD  

(148)  

(149)      

(150)   .  

(151)                ! "   .   

(152) 

(153)      !! "#!  $  %&&" ' & ()! "&   & )*! 

(154)  & ()!&!) + % # & ," 

(155) - .. /0!# & %   !## #  &.

(156) . »ÇYÁ+   

(157)     HQGRJHQRXV PRUSKLQHV /DQFHW LL 6M|OXQG %+ (ULNVRQQ 0%( 7KH LQIOXHQFH RI QDOR[RQH. RQ. FRQGLWLRQLQJ. DQDOJHVLD. SURGXFHG. VWLPXODWLRQ. E\ %UDLQ. SHULSKHUDO 5HV.          !" !# $" % & % $' "%( !("!$! ( )!(" *'+ !" . , - )!$!( .,+ &RQVHQVXV &RQIHUHQFH - $P 0HG $VVRF  0RRUH. 65. HOHFWULFDO. 6KXUPDQ. VWLPXODWLRQ. - DQG. &RPELQHG. QHXURPXVFXODU. WUDQVFXWDQHRXV. HOHFWULFDO.  

(158)     

(159)      

(160)  

(161) 

(162)     

(163)  

(164)    

(165)   .   

(166)       ! "# $  % &!'!&$!( $( $)$ * + &, '

(167)  ( )

(168) - &$(  $! .) / 

(169)    "$(

(170) $ ((  

(171) - / 0$(!&

(172)  ' &   

(173) $ &!'!&$!( ( (& # &$ 12  

(174)     

(175)   

(176)  

(177)  !  !

(178)  

(179) " #   

(180) $

(181) ! !   

(182)     .

(183) DêknD ¬êknš\. . &RPSDULVRQRIWKH7KHUDSHXWLF(IIHFWVRI2QH6KRW  (OHFWURDFXSXQFWXUHDQG6XUIDFH(OHFWURDFXSXQFWXUHLQ  &HUYLFDO3DLQ3DWLHQWV Ru-Lan Hsieh,. Wen-Chung Lee1. Department of Physical Medicine and Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei; 1Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei.. The objective of this study was to investigate the therapeutic effects of one-shot electroacu-puncture (EA) versus one-shot surface electroacupuncture (SEA) in cervical pain patients. A total of 51 patients were recruited in this randomized control study. Control group (n=13) received medication only. EA group (n=21) received medication plus one-shot of EA.SEA group (n=17) received medication plus one-shot of SEA. Therapeutic effects were measured by Visual Analogue Scale (VAS), body surface score, pain pressure threshold and Quebec Back Pain Disability Scale. The therapeutic effects were shown immediately after the one-shot treatment in both the EA group and the SEA group. In the EA group, the VAS improved 1.99 (p<0.0001), and body surface score was improved 3.52 (p<0.001). In the SEA group, the VAS was improved 1.70 (p<0.0001), and body surface score was improved 1.96 (p<0.005) as well. One week after the treatment, the VAS value in the EA group was improved 2.71 (p<0.0001), whereas the VAS value in the SEA group was improved 2.67 (p<0.0001). The pain surface scores in all three groups had decreased significantly after treatment, but no significant difference was found. Quebec back pain disability scale was improved 10.0 (p<0.005) in the EA group, and was improved 12.4 (p<0.005) in the SEA group 3 days after treatment. One week after treatment, the improved scales were shown with 18.6 (p<0.0005), 22.7 (p<0.005) respectively in the EA group and the SEA group. The improvements were not shown with significant difference between the two groups. Our conclusion is that one-shot treatment of both EA and SEA is effective for pain relief and functional disability improvement in cervical pain patients. Therefore, one-shot SEA treatment is more advised due to the rarity of side effect and the convenience of application. ( J Rehab Med Assoc ROC 2002; 30(1): 1 - 7 ) Key words: cervical pain, electroacupuncture, surface electroacupuncture.     . !"  #. 'HSDUWPHQW RI 3K\VLFDO 0HGLFLQH DQG 5HKDELOLWDWLRQ 6KLQ .RQJ :X. +R6X 0HPRULDO +RVSLWDO 1R  :HQ &KDQJ 5RDG 6KLK /LQ 'LVWULFW 7DLSHL. 7HO.  

(184)  H[W  . )D[.  

(185) .  7DLZDQ.

(186)

參考文獻

相關文件

Edit Video Layer (Right click and drag, left click to set). Drag the strip

SF12144A 張基晟 比較 Nanoplatin 併用 Pemetrexed 和 Cisplatin 併用 Pemetrexed 作為第一線治 療用於非鱗狀細胞性之非小細胞肺癌

• Learn to show the body props and to make the sound effects.. • Teamwork to play the fairy

replacement therapy」 ,請儘可能明確列出給予 外源性 FVIII 置換療法之標準 (criteria),包 括治療時機和用量。統計部分亦請說明此指 標將如何估計,針對 missing value 的插補方 法

SF15140A 楊勝舜 利用 JKB-122 評估對於經干擾素(長效 型或短效型)或干擾素和 Ribavirin 組合 治療沒有反應的 C 型肝炎病毒陽性患 者之肝臟功能 (丙胺酸轉胺酶

本案件為乳癌標準化化學藥物治療與個人化化學治 療處方手術前化學治療療效比較之國內多中心研 究,於 2008 年 8 月 1 日由

評估以 S-649266 或最佳現有療法進行治療罹患抗 Carbapenem 革蘭氏陰性菌感染的患者的臨床結果 (包括詴驗用藥 S-649266

近年來,大蒜對人體保健及疾病治療的研究陸續發表,許多人開始重視大蒜在醫療上,以及保健方面